Stock 4130 GENOVATE BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Genovate Biotechnology Co., Ltd.

Equities

4130

TW0004130000

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 04/07/2024 am IST 		5-day change 1st Jan Change
24.6 TWD -0.61% Intraday chart for Genovate Biotechnology Co., Ltd. -0.40% -7.52%
31/05 Genovate Biotechnology Co., Ltd. Appoints Su, Lai-Shou as a Member of Audit Committee CI
31/05 Genovate Biotechnology Co., Ltd. Appoints Su, Lau-Shou as Independent Director CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Genovate Biotechnology Co., Ltd. Appoints Su, Lai-Shou as a Member of Audit Committee
CI
Genovate Biotechnology Co., Ltd. Appoints Su, Lau-Shou as Independent Director
CI
Genovate Announces Plans to Submit New Drug Application for PMR to the U.S. Food & Drug Administration in the Second Half of 2025
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Genovate Biotechnology Co., Ltd. Announces Members of the Company's 5th Remuneration Committee
CI
Genovate Biotechnology Co., Ltd. Announces Cash Dividend, Payable August 7, 2023
CI
Genovate Biotechnology Co., Ltd. Approves Election of Directors
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Genovate Biotechnology Co., Ltd. and CSPC Pharmaceutical Group Limited Sign the Agreement on Technology Licensing and Co-Development of DBPR108 in Mainland China
CI
Genovate Biotechnology Co., Ltd. Announces Resignation of Chen, Tehfang as Audit Committee Member and Convener of the Remuneration Committee, Effective April 10, 2023
CI
Genovate Biotechnology Co., Ltd. Announces Resignation of Chen, Tehfang as Independent Director, Effective April 10, 2023
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Genovate Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4130 Stock
  4. News Genovate Biotechnology Co., Ltd.